Stryker is trading at $292.95, up +4.02%, amid a broad healthcare rally.
- The sector ETF is up 2.12%, supported by strong earnings from UnitedHealth and Johnson & Johnson.
- Search results showed no clear Stryker-specific announcement explaining the October 15 rise; earlier product and partnership news do not establish the cause.
- The evidence best supports sector-led strength, but does not confirm direct causation.